| Evidence for CALM in directing VAMP2 trafficking A Harel, F Wu, MP Mattson, CM Morris, PJ Yao Traffic 9 (3), 417-429, 2008 | 175 | 2008 |
| Clathrin assembly protein AP180 and CALM differentially control axogenesis and dendrite outgrowth in embryonic hippocampal neurons I Bushlin, RS Petralia, F Wu, A Harel, MR Mughal, MP Mattson, PJ Yao Journal of Neuroscience 28 (41), 10257-10271, 2008 | 83 | 2008 |
| Cerebellar lobule atrophy and disability in progressive MS S Cocozza, M Petracca, E Mormina, K Buyukturkoglu, K Podranski, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (12), 1065-1072, 2017 | 68 | 2017 |
| Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab JR Thornton, A Harel Multiple Sclerosis and Related Disorders 44, 102341, 2020 | 63 | 2020 |
| Progressive multifocal leukoencephalopathy in a patient with progressive multiple sclerosis treated with ocrelizumab monotherapy A Patel, J Sul, ML Gordon, J Steinklein, S Sanguinetti, B Pramanik, ... JAMA neurology 78 (6), 736-740, 2021 | 47 | 2021 |
| Novel agents for relapsing forms of multiple sclerosis R Straus Farber, A Harel, F Lublin Annual review of medicine 67, 309-321, 2016 | 45 | 2016 |
| Adolescents and genetic testing: what do they think about it? A Harel, D Abuelo, A Kazura Journal of Adolescent Health 33 (6), 489-494, 2003 | 43 | 2003 |
| Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia A Harel, S Horng, T Gustafson, A Ramineni, RS Farber, M Fabian Journal of neurovirology 24 (5), 652-655, 2018 | 36 | 2018 |
| CALM, a clathrin assembly protein, influences cell surface GluR2 abundance A Harel, MP Mattson, PJ Yao Neuromolecular medicine 13, 88-90, 2011 | 31 | 2011 |
| Phase-sensitive inversion-recovery MRI improves longitudinal cortical lesion detection in progressive MS A Harel, A Ceccarelli, C Farrell, M Fabian, J Howard, C Riley, A Miller, ... PloS one 11 (3), e0152180, 2016 | 25 | 2016 |
| Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors X Boumaza, B Bonneau, D Roos‐Weil, C Pinnetti, S Rauer, L Nitsch, ... Annals of neurology 93 (2), 257-270, 2023 | 24 | 2023 |
| Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC) S Klineova, A Harel, RS Farber, T DeAngelis, Y Zhang, R Hentz, ... Multiple Sclerosis and Related Disorders 55, 103153, 2021 | 19 | 2021 |
| Retinal vasculopathy with cerebral leukoencephalopathy (RVCL): A rare mimic of tumefactive MS J Raynowska, DP Miskin, B Pramanik, S Asiry, T Anderson, J Boockvar, ... Neurology 91 (15), e1423-e1428, 2018 | 19 | 2018 |
| The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS M Pardini, M Petracca, A Harel, L Fleysher, N Oesingmann, G Bommarito, ... NeuroImage: Clinical 16, 111-115, 2017 | 19 | 2017 |
| Brain microstructural injury occurs in patients with RRMS despite ‘no evidence of disease activity’ A Harel, D Sperling, M Petracca, A Ntranos, I Katz-Sand, S Krieger, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (9), 977-982, 2018 | 18 | 2018 |
| Outcome of Progressive Multifocal Leukoencephalopathy Treated by Interleukin‐7 R Lajaunie, I Mainardi, J Gasnault, V Rousseau, AG Tarantino, A Sommet, ... Annals of Neurology 91 (4), 496-505, 2022 | 14 | 2022 |
| Dietary factors in experimental autoimmune encephalomyelitis and multiple sclerosis: A comprehensive review C Valburg, A Sonti, JNH Stern, S Najjar, A Harel Multiple Sclerosis Journal 27 (4), 494-502, 2021 | 14 | 2021 |
| A single-health system case series of new-onset CNS inflammatory disorders temporally associated with mRNA-based SARS-CoV-2 vaccines AA Ballout, A Babaie, M Kolesnik, JY Li, N Hameed, G Waldman, ... Frontiers in neurology 13, 796882, 2022 | 12 | 2022 |
| Progressive Multifocal Leukoencephalopathy in a Patient on Ocrelizumab Monotherapy (4875) J Sul, A Patel, ML Gordon, J Steinklein, S Sanguinetti, B Pramanik, ... Neurology 94 (15 Supplement), 2020 | 11 | 2020 |
| An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of pain B Reinhart, WF Goins, A Harel, S Chaudhry, JR Goss, N Yoshimura, ... Molecular Therapy-Methods & Clinical Development 3, 2016 | 8 | 2016 |
